INTERPACE BIOSCIENCES, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Interpace Biosciences, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Interpace Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 4.4M shares, a 1.92% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 4.4M +83K +1.92% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 4.38M +65K +1.51% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 4.38M +65K +1.51% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 4.35M +54.7K +1.27% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 4.32M +75.5K +1.78% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 4.31M +81.5K +1.93% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 4.31M +85K +2.01% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 4.3M +101K +2.41% Dec 31, 2022 10-K 2024-04-01
Q3 2022 4.25M +71.9K +1.72% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 4.23M +107K +2.6% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 4.23M +114K +2.76% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 4.2M +140K +3.45% Dec 31, 2021 10-K 2023-03-27
Q3 2021 4.17M +133K +3.29% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 4.12M +86.2K +2.14% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 4.11M +69.2K +1.71% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 4.06M +135K +3.44% Dec 31, 2020 10-K 2022-03-31
Q3 2020 4.04M -34.2M -89.4% Sep 30, 2020 10-Q 2021-01-20
Q2 2020 4.04M -34.2M -89.4% Jun 30, 2020 10-Q/A 2021-01-19
Q1 2020 4.04M -34.1M -89.4% Mar 31, 2020 10-Q/A 2021-01-19
Q4 2019 3.92M +1.05M +36.6% Dec 31, 2019 10-K 2022-03-31
Q3 2019 38.2M +9.9M +35% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 38.2M +10M +35.5% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 38.1M +10.2M +36.7% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 2.87M -25M -89.7% Dec 31, 2018 10-K/A 2021-01-19
Q3 2018 28.3M +5.38M +23.5% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 28.2M +8.11M +40.4% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 27.9M +21.1M +314% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 27.8M +25.7M +1179% Dec 31, 2017 10-K 2019-03-21
Q3 2017 22.9M +4.75M +26.1% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 20.1M +1.93M +10.6% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 6.72M -11.4M -63% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 2.18M +410K +23.2% Dec 31, 2016 10-K 2018-03-23
Q3 2016 18.2M +1.44M +8.63% Sep 30, 2016 10-Q 2016-11-17
Q2 2016 18.2M +1.96M +12.1% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 18.2M +1.96M +12.1% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 1.77M -13.6M -88.5% Dec 31, 2015 10-K 2017-03-31
Q3 2015 16.7M +1.36M +8.86% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 16.2M +843K +5.49% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 16.2M +882K +5.76% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 15.4M +191K +1.26% Dec 31, 2014 10-K 2016-03-30
Q3 2014 15.4M +210K +1.39% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 15.4M +171K +1.13% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 15.3M +306K +2.04% Mar 31, 2014 10-Q/A 2014-08-19
Q4 2013 15.2M +204K +1.36% Dec 31, 2013 10-K 2015-03-05
Q3 2013 15.1M +205K +1.37% Sep 30, 2013 10-Q/A 2014-09-30
Q2 2013 15.2M +246K +1.65% Jun 30, 2013 10-Q 2013-08-05
Q1 2013 15M +117K +0.79% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 15M +221K +1.5% Dec 31, 2012 10-Q/A 2014-09-30
Q3 2012 14.9M +221K +1.5% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 14.9M +222K +1.51% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 14.9M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 14.7M +354K +2.46% Dec 31, 2011 10-K 2013-03-15
Q3 2011 14.7M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 14.7M Jun 30, 2011 10-Q 2011-08-10
Q4 2010 14.4M Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.